semaglutide prediabetes progression to type 2 diabetes trial once a week in adults with overweight or obesity, with or without in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a Efficacy and safety of once-weekly

Your GP may prescribe anti-emetic medications if nausea is severe

Systemic side effects Nausea is the most commonly reported side effect of GLP-1 therapy, and it is a medication effect, not an injection technique issue

Total FM decreased by 19.3%, and visceral FM by 27.4%, while LBM declined by ~ 10%

Better Kidney Health GLP-1 medicines lowered the chance of kidney damage, especially in people already at risk

[DOI] [PubMed] [Google Scholar] 108.Packer M, Zile MR, Kramer CM, et al

HbA1c changes were applied in year 1 of the respective treatment line, after which HbA1c risk factor progression was based on the UKPDS Outcomes Model 2 equation published by Leal et al